Loading...
Docoh

Evolent Health (EVH)

News

From Benzinga Pro
What 6 Analyst Ratings Have To Say About Evolent Health
3 Aug 22
Analyst Ratings
Within the last quarter, Evolent Health (NYSE:EVH) has observed the following analyst ratings:
RBC Capital Maintains Outperform on Evolent Health, Raises Price Target to $44
3 Aug 22
News, Price Target, Analyst Ratings
RBC Capital analyst Sean Dodge maintains Evolent Health (NYSE:EVH) with a Outperform and raises the price target from $40 to $44.
BTIG Maintains Buy on Evolent Health, Raises Price Target to $50
3 Aug 22
News, Price Target, Analyst Ratings
BTIG analyst David Larsen maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $45 to $50.
Piper Sandler Maintains Overweight on Evolent Health, Raises Price Target to $40
3 Aug 22
News, Price Target, Analyst Ratings
Piper Sandler analyst Jessica Tassan maintains Evolent Health (NYSE:EVH) with a Overweight and raises the price target from $35 to $40.
12 Health Care Stocks Moving In Tuesday's After-Market Session
2 Aug 22
Movers
Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is 19228.0% of its average volume over the last 100 days.
Evolent Health Q2 EPS $0.10 Beats $0.04 Estimate, Sales $319.90M Beat $297.77M Estimate
2 Aug 22
Earnings, News
Evolent Health (NYSE:EVH) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.04 by 150 percent. This is a 600 percent increase over losses of $(0.02) per share from the same
Earnings Scheduled For August 2, 2022
2 Aug 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Evolent Health's Earnings: A Preview
1 Aug 22
Earnings
Evolent Health (NYSE:EVH) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Evolent Health will report an earnings per share (EPS) of $0.04.
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
29 Jul 22
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
RBC Capital Initiates Coverage On Evolent Health with Outperform Rating, Announces Price Target of $40
29 Jul 22
News, Price Target, Initiation, Analyst Ratings
RBC Capital analyst Sean Dodge initiates coverage on Evolent Health (NYSE:EVH) with a Outperform rating and announces Price Target of $40.
Evolent Expands Its Portfolio For Musculoskeletal Conditions With This Deal
29 Jun 22
Biotech, Earnings, M&A, News, Health Care, General
Evolent Health to Acquire IPG from TPG Growth for $375M Plus Additional Contingent Consideration of up to $87M
29 Jun 22
M&A, News
Evolent Health, Inc.
4 Analysts Have This to Say About Evolent Health
21 Jun 22
Analyst Ratings
Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter:
Cowen & Co. Maintains Outperform on Evolent Health, Raises Price Target to $50
21 Jun 22
News, Price Target, Analyst Ratings
Cowen & Co. analyst Charles Rhyee maintains Evolent Health (NYSE:EVH) with a Outperform and raises the price target from $48 to $50.

Press releases

From Benzinga Pro
Evolent Health to Participate in the CG Growth Conference
10 Aug 22
Press Releases
WASHINGTON, Aug. 10, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent"), a health care company that delivers proven clinical solutions to payers and providers, today announced that Chief Executive
Evolent Health Announces Second Quarter 2022 Results
2 Aug 22
Earnings, Press Releases
Announces Four Operating Partner Additions WASHINGTON, Aug. 2, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a health care company that delivers proven clinical and administrative solutions to payers and
Evolent Health Named to Parity.org's Best Companies for Women to Advance List 2022
1 Aug 22
Press Releases
Company makes the ParityLIST for the third straight year. WASHINGTON, Aug. 1, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a health care company that delivers proven clinical and administrative solutions to
Evolent Health, Inc. to Release Second Quarter Operating Results and Host Conference Call on Tuesday, August 2, 2022
15 Jul 22
Press Releases
WASHINGTON, July 15, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its
Shareholder Alert - The M&A Class Action Firm Announces an Investigation of Evolent Health, Inc. - EVH
30 Jun 22
Press Releases
NEW YORK, June 30, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm
EVOLENT HEALTH TO ACQUIRE IPG
29 Jun 22
Earnings, Press Releases
- Expected to Accelerate Evolent Health's Position as a Leading Provider of Value-Based Specialty Care Solutions - Expands Evolent's Value-Based Specialty Care Solutions Portfolio to Musculoskeletal Conditions-
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Evolent Health, Inc.
27 May 22
Press Releases
Wilmington, Delaware--(Newsfile Corp. - May 27, 2022) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Evolent Health, Inc. (NYSE:EVH) on behalf of stockholders.To learn more